November 2017

 

In this Issue

TEVAR

Strategizing Success

Issue

Supplement

Fall Supplement

Guest Chief Medical Editors’ Page

TEVAR: Strategizing Success

By Edward Y. Woo, MD; and Ian M. Loftus, MD, FRCS

COVER STORIES

Classification of Aortic Pathologies

A brief review of thoracic aortic aneurysms and acute aortic syndrome, including classic aortic dissection, intramural hematoma, and penetrating aortic ulcer.

By Sharif H. Ellozy, MD

Preoperative Risk Assessment for Optimal TEVAR Outcomes

Evaluating which imaging, risk stratification, and system-specific options to consider before thoracic endovascular aortic repair.

By Tristan R. A. Lane, PhD, BSc, MBBS, MRCS; Sadie Syed, MD, MBBS, FRCA; Richard Gibbs, MD, MBChB, FRCS; and Colin D. Bicknell, MD, FRCS

Thoracic Aortic Aneurysms: At What Size Should We Intervene?

Key factors to consider when selecting patients for TAA repair.

By Robert J. Hinchliffe, MD, FRCS; and Paul Hollering

Ask the Experts: When and How Do You Survey a Small TAA?

Experts discuss how the definition of small AAAs and TAAs has changed in the past decade and how best to treat them.

With Timur P. Sarac, MD; Dittmar Böckler, MD, PhD; Moritz S. Bischoff, MD; Katrin Meisenbacher, MD; and Ian M. Loftus, MD, FRCS

Identifying the Appropriate Thoracic Device Size

How to correctly size a thoracic device in diameter, landing zone, and length.

By Michael E. Barfield, MD; and Thomas S. Maldonado, MD

The Aberrant Vertebral Artery With Aortic Arch Pathology

A discussion of the indications for revascularization and technical tips for preservation.

By Tareq M. Massimi, MD; and Edward Y. Woo, MD

TEVAR and Reintervention: How to Manage Endoleaks and False Lumen Perfusion

Treatment approaches for thoracic aortic aneurysm and thoracic aortic dissection failures.

By Zachary Kostun, MD; and Manish Mehta, MD, MPH

Ask the Experts: What Is Your Protocol for Following Patients After TEVAR?

Expects comment on their approach to surveillance for patients with aneurysmal disease versus aortic dissection.

With Rajesh K. Malik, MD, FACS, RPVI; Tilo Kölbel, MD, PhD; Patrick Kelly, MD; and James F. McKinsey, MD

FEATURED PROGRAM

Sponsored by Philips Volcano

Looking Forward: Predictions for Office-Based Labs

With Donald S. Cross, MD, FACC; Alberto Gonzalez, MD, FACS; and Kenneth J. Wright, MD, FACS

EUROPEAN FEATURED TECHNOLOGY

Sponsored by QualiMed

Inert Technology: Actively Making a Difference in Drug-Eluting Stent Designs

EUROPEAN FEATURED TECHNOLOGY

Sponsored by Cardionovum GmbH

State of the Art: The Legflow Drug-Coated Balloon for Endovascular Treatment of Long SFA Lesions

Initial study results show the promise of this new-generation DCB in complex lesions.

By Koen Deloose, MD; Joren Callaert, MD; and Marc Bosiers, MD

DEPARTMENTS

Innovations

A preview of today's new products.

An Interview With Stephen A. Black, MD, FRCS(Ed), FEBVS

Mr. Black discusses when stent placement is ideal in patients with venous disease, the need for more accurate tools to measure inflow, and what’s next after ATTRACT.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.